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NOTES AND COMMENTS

Letters To the Editor
More About
Nurse Clinicians

Comments on
Australia Antigen

To the editor:
Our article (Vol. 18, No. 3, FaU,
1970) describing the Health Nurse
Clinician was not intended to offer a
solution to the problem of rising health
care costs. The increasing use of paramedical personnel certainly has an
impact on cost, and nurses have led
the way in delegating duties to others
with less professional training.
In Vol. 19, No. 1, Letter to the
Editor, Mrs. Zonca points to the law
of supply and demand as fundamental
to rising costs. The extension of the
physician's capability in patient care,
in a collegial relationship with the
Health Nurse Clinician, strongly suggests a possibility of lowering costs.
I do not agree that "No matter what
we do, hospital cost will continue to
increase." The fact is what we do is
the only thing that can influence the
cost.
C. E. Rupe, M.D.

To the editor:
In reference to a recent article by
Hayashi and LoGrippo (Vol. 19, No. 1,
1971), the authors found Australia antigen (Au) in 34% of institutionalized
patients during a hepatitis epidemic
which on all clinical grounds appeared
to be "infectious" hepatitis. They concluded: (1) that Au is associated with
infectious as well as serum hepatitis
and (2) that the test for Au was relatively insensitive since it was negative
in 66% of the hepatitis cases.
There would appear to be a third
and more reasonable interpretation of
these data, namely: (a) that, as in all
other large institutions, there was a
high frequency of endemic anicteric
hepatitis much of which was Au positive (The frequency of Au in Down's
and non-Down's patients cited is
wholly consistent with that found in
other institutions where no such infectious hepatitis outbreak has occurred); (b) that the hepatitis outbreak
was indeed Au negative infectious hepatitis and that the authors merely
measured pre-existing Au antigen
levels.
The data are now fairly convincing
that Au is associated with only one
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form of the hepatitis virus. This is
based primarily on the distinctions
between MS-1 and MS-2 viruses isolated at the Willowbrook State School
and on the repeated failure to demonstrate the appearance of Au in relation
to any point source hepatitis epidemic.
One can not contradict this accumulated evidence with data derived from
institutions for the mentally retarded
where the incidence of Au has consistently been shown to be high and
particularly from an institution where
no pre-epidemic samples were available for Au testing. Furthermore the
authors present no control data on the
incidence of Au, CRP, IgM and SGPT
in their institutionalized patients who
did not have clinical hepatitis. These
data are crucial if one is to attempt to
causally relate the presence of Au with
the epidemic described.

Authors' Reply
To the editor:
We accept Drs. Alter and Holland's
third interpretation of our data (par.
2b of their letter). Their elaboration of
our discussion is welcomed because it
must not have been clear in our interpretation where we stated, ". . . we
questioned whether our outbreak was
I H or SH in nature. If I H and SH
varieties were both present among patients, it would be difficult to explain
in a relatively new institution the mixed
hepatitis varieties present with abrupt
onset and sudden termination in four
to six weeks " (par. 1, page 32 of our
pubhcation).
Although we do not have data on
the incidence of Au for 1962 among
the institutional personnel, nor of the
children before they developed hepatitis, the fact remains that testing for
Au in clinically ill patients does not
differentiate SH from I H . In addition,
Au-antigen positive patients do not
convincingly develop Au-antibodies
following convalescence. More sensitive radioactive methods are being investigated for this purpose. However,
until a more sensitive serologic method
for demonstrating serum conversion
from negative to positive antibody response to Au from active infection, and
not from parental administration oj
homologous blood products, the association of Au to hepatitis virus protein
warrants clarification from a virologic
and immunologic standpoint.
Drs. Alter and Holland state that
we have no crucial control study on
the incidence of Au, CRP, IgM and
SGPT values. Normal serum levels for
these factors are given under "Materials and Methods" in our publica-

In summary, without pre-epidemic
sera for Au determination and without
testing "non-hepatitis" controls, the
authors are unjustified in drawing any
conclusions regarding the relationship
of Au to the hepatitis epidemic reported.
Harvey J. Alter, M.D.,
Senior Investigator
Paul V. Holland, M.D.,
Assistant Chief
Blood Bank Department-Clinical
Center, National Institutes of
Health, Bethesda, Md.
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tion, with suitable references to our
previous publications. We are not
claiming that the presence of Au in
34% of the I H patients in institutionalized children and 23% (57 of
244 patients) admitted to our hospital
with active virus hepatitis should be
considered a "causal relation to the
presence" (as they put it) of Au in our
studies. We suggested that "These tests
appear to reflect the host's responses
to nonspecific inflammatory conditions " (par. 1, page 31).
Since there is no serologic test for
IH, as there is for Au which is hypothetically assumed to be associated
with SH, how can one differentiate I H
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from SH in acute hepatitis cases by
testing for Au only? This is particularly
so if we assume, as they suggest, that
Au in our study is present as preexisting Au antigen levels in the presence of clinically active I H . Clinicians
should not conclude that an active
case of virus hepatitis is SH simply
because the serum is Au-positive. This
is an ever-present situation in clinical
hepatitis and the purpose for our conclusion. We stand firm on our conclusion that more virologic and immunologic evidence is necessary before
this moot question can be resolved.
G. A. LoGrippo, M.D.
H. Hayashi, Ph.D.

